Tiocarlide

ANTIINFECTIVES FOR SYSTEMIC USE

Key facts

Tiocarlide is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family. Recorded indications include Pulmonary tuberculosis.

• Molecular targets: Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family (1 listed in DrugCentral).
• Indications: Pulmonary tuberculosis.
• ATC code: J04AD02 (Thiocarbamide derivatives).
• Molecular formula: C23H32N2O2S; molecular weight 400.58 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Pulmonary tuberculosis

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family	—	unknown	IC50 7.66

ATC classification

ATC code	Therapeutic hierarchy
J04AD02	ANTIINFECTIVES FOR SYSTEMIC USE › ANTIMYCOBACTERIALS › DRUGS FOR TREATMENT OF TUBERCULOSIS › Thiocarbamide derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Tiocarlide is on its molecule page.

• Molecular formula: C₂₃H₃₂N₂O₂S
• Molecular weight: 400.58 g/mol
• CAS number: 910-86-1
• InChIKey: BWBONKHPVHMQHE-UHFFFAOYSA-N
• PubChem CID: 3001386

CC(C)CCOC1=CC=C(NC(=S)NC2=CC=C(OCCC(C)C)C=C2)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tiocarlide used for?

DrugCentral lists the following indications for Tiocarlide: Pulmonary tuberculosis.

How does Tiocarlide work?

Its molecular targets in DrugCentral include Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family.

What is the chemical formula of Tiocarlide?

Tiocarlide has the molecular formula C23H32N2O2S and a molecular weight of 400.58 g/mol.

Sources

• DrugCentral drug card 2673 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL214920 — compound record and bioactivity
• PubChem CID 3001386 — chemical identifiers
• DrugBank DB13608 — drug record
• FDA UNII 43M23X81Y2 — substance identity

How this page is built: methodology · editorial policy & corrections.